KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Equity Income (2020 - 2025)

Amgen (AMGN) has 6 years of Equity Income data on record, last reported at $10.0 million in Q3 2025.

  • For Q3 2025, Equity Income rose 135.71% year-over-year to $10.0 million; the TTM value through Sep 2025 reached -$20.0 million, down 17.65%, while the annual FY2024 figure was $10.0 million, 190.91% up from the prior year.
  • Equity Income reached $10.0 million in Q3 2025 per AMGN's latest filing, up from -$18.0 million in the prior quarter.
  • Across five years, Equity Income topped out at $97.0 million in Q4 2021 and bottomed at -$305.0 million in Q1 2022.
  • Average Equity Income over 5 years is -$42.8 million, with a median of -$11.0 million recorded in 2025.
  • Peak YoY movement for Equity Income: soared 234.72% in 2021, then plummeted 1471.43% in 2022.
  • A 5-year view of Equity Income shows it stood at $97.0 million in 2021, then crashed by 283.51% to -$178.0 million in 2022, then surged by 84.27% to -$28.0 million in 2023, then soared by 96.43% to -$1.0 million in 2024, then skyrocketed by 1100.0% to $10.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Income were $10.0 million in Q3 2025, -$18.0 million in Q2 2025, and -$11.0 million in Q1 2025.